{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:01:23Z","timestamp":1760266883962},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s10165-008-0062-z","type":"journal-article","created":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T10:21:46Z","timestamp":1208168506000},"page":"399-402","source":"Crossref","is-referenced-by-count":5,"title":["A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy"],"prefix":"10.1093","volume":"18","author":[{"given":"Tomohiro","family":"Kameda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuharu","family":"Kittaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Susaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"62_CR1","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Carazo JL, Mahiques Santos L, Oliver Martinez V. Safety of etanercept in psoriasis: a critical review. Drug Saf. 2006;29(8):675\u201385.","DOI":"10.2165\/00002018-200629080-00004"},{"issue":"10","key":"62_CR2","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","volume":"57","author":"NL Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR. Onset of multiple sclerosis associated with anti-TNF therapy. Neurology. 2001;57(10):1885\u20138.","journal-title":"Neurology"},{"issue":"4","key":"62_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.mcg.0000155126.82171.32","volume":"39","author":"PJ Enayati","year":"2005","unstructured":"Enayati PJ, Papadakis KA. Association of antitumor necrosis factor therapy with the development of multiple sclerosis. J Clin Gastroenterol. 2005;39(4):303\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"62_CR4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/01.WNL.0000158681.29117.8B","volume":"64","author":"C Richez","year":"2005","unstructured":"Richez C, Blaco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIPD in patients receiving tumor necrosis factor-alpha blockers. Neurology. 2005;64(8):1468\u201370.","journal-title":"Neurology"},{"key":"62_CR5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/s10165-006-0530-2","volume":"17","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto M, Takahashi H, Wakasugi H, Sukawa Y, Saito M, Suzuki C, et al. Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis. Mod Rheumatol. 2007;17:72\u20134.","journal-title":"Mod Rheumatol"},{"key":"62_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaad.2005.05.039","volume":"54","author":"SA Sukal","year":"2006","unstructured":"Sukal SA, Nadiminti L, Granstein RD. Etanercept and demyelinating disease in a patient with psoriasis. J Am Acad Dermatol. 2006;54:160\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"62_CR7","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al. Demyelination occurring during anti-tumor necrosis factor \u03b1 therapy for inflammatory arthritides. Arthritis Rheum. 2001;44(12):2862\u20139.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"62_CR8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2710.2006.00779.x","volume":"31","author":"HF Cay","year":"2006","unstructured":"Cay HF, Gungor HA, Sezer I, Kacar C, Balci N. Adverse effect of TNF-alpha blocker? Demyelination in an ankylosing spondylitis patient: a case report. J Clin Pharm Ther. 2006;31(6):645\u20138.","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"62_CR9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","volume":"44","author":"WH Robinson","year":"2001","unstructured":"Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor \u03b1 antagoism: By what mechanisms could tumor necrosis factor \u03b1 antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum. 2001;44 (9):1977\u201383.","journal-title":"Arthritis Rheum"},{"key":"62_CR10","doi-asserted-by":"crossref","unstructured":"Tanaka M, Tanaka K, Komori M, Saida T. Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody. J Neurol Neurosurg Psychiatry. 2007;78:990\u20132.","DOI":"10.1136\/jnnp.2006.114165"},{"key":"62_CR11","first-page":"134","volume":"22","author":"MD Magnano","year":"2004","unstructured":"Magnano MD, Robinson WH, Genovese MC. Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol. 2004;22:134\u201340.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-008-0062-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:26:58Z","timestamp":1646843218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-008-0062-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s10165-008-0062-z","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}